Literature DB >> 24132893

On the outside, looking in: a review and evaluation of the comparability of blood and brain "-omes".

Daniel S Tylee1, Daniel M Kawaguchi, Stephen J Glatt.   

Abstract

In this article, we review studies detailing the correspondence between peripheral blood and brain tissue across various domains of high-throughput -omic analysis in order to provide a context for evaluating blood-based biomarker studies. Specifically, we reviewed seven studies comparing patterns of DNA methylation (i.e., an aspect of the epigenome), eight articles comparing patterns of gene expression (i.e., the transcriptome), and three articles comparing patterns of protein expression (i.e., the proteome). Our review of the epigenomic literature suggests that CpG-island methylation levels are generally highly correlated (r = 0.90) between blood and brain. Our review of transcriptomic studies suggests that between 35% and 80% of known transcripts are present in both brain and blood tissue samples; estimates of cross-tissue correlation in expression levels were found to range from 0.25 to 0.64, with stronger correlations observed among particular subsets of genes. Relative to the epigenome and transcriptome, the proteome has not been as fully compared between brain and blood samples, highlighting an important area for future work as whole-proteome profiling methods mature. Beyond reviewing the relevant studies, we discuss some of the assumptions, methodological issues, and gaps in knowledge that should be addressed in order to better understand how the multiple "-omes" of the brain are reflected in the peripheral blood. A better understanding of these relationships is a critical precursor to the validation of biomarkers for brain disorders.
© 2013 Wiley Periodicals, Inc.

Entities:  

Keywords:  blood; brain; epigenome; gene expression; genome; methylation; neuropsychiatry; proteome; transcriptome

Mesh:

Substances:

Year:  2013        PMID: 24132893     DOI: 10.1002/ajmg.b.32150

Source DB:  PubMed          Journal:  Am J Med Genet B Neuropsychiatr Genet        ISSN: 1552-4841            Impact factor:   3.568


  86 in total

1.  Relation of Promoter Methylation of the Oxytocin Gene to Stressful Life Events and Depression Severity.

Authors:  Simon Sanwald; Maximilian Gahr; Katharina Widenhorn-Müller; Carlos Schönfeldt-Lecuona; Kerstin Richter; Bernhard J Connemann; Thomas Kammer; Christian Montag; Markus Kiefer
Journal:  J Mol Neurosci       Date:  2019-11-25       Impact factor: 3.444

2.  A DNA methylation site within the KLF13 gene is associated with orexigenic processes based on neural responses and ghrelin levels.

Authors:  L Wiemerslage; R Islam; C van der Kamp; H Cao; G Olivo; F Ence-Eriksson; S Castillo; A L Larsen; M Bandstein; L S Dahlberg; E Perland; V Gustavsson; J Nilsson; H Vogel; A Schürmann; E-M Larsson; M Rask-Andersen; C Benedict; H B Schiöth
Journal:  Int J Obes (Lond)       Date:  2017-02-14       Impact factor: 5.095

3.  Epigenetic Aging in Major Depressive Disorder.

Authors:  Laura K M Han; Moji Aghajani; Shaunna L Clark; Robin F Chan; Mohammad W Hattab; Andrey A Shabalin; Min Zhao; Gaurav Kumar; Lin Ying Xie; Rick Jansen; Yuri Milaneschi; Brian Dean; Karolina A Aberg; Edwin J C G van den Oord; Brenda W J H Penninx
Journal:  Am J Psychiatry       Date:  2018-04-16       Impact factor: 18.112

4.  Epigenetic signature for attention-deficit/hyperactivity disorder: identification of miR-26b-5p, miR-185-5p, and miR-191-5p as potential biomarkers in peripheral blood mononuclear cells.

Authors:  Cristina Sánchez-Mora; María Soler Artigas; Iris Garcia-Martínez; Mireia Pagerols; Paula Rovira; Vanesa Richarte; Montse Corrales; Christian Fadeuilhe; Natàlia Padilla; Xavier de la Cruz; Barbara Franke; Alejandro Arias-Vásquez; Miguel Casas; Josep-Antoni Ramos-Quiroga; Marta Ribasés
Journal:  Neuropsychopharmacology       Date:  2018-12-19       Impact factor: 7.853

5.  Transcriptome outlier analysis implicates schizophrenia susceptibility genes and enriches putatively functional rare genetic variants.

Authors:  Jubao Duan; Alan R Sanders; Winton Moy; Eugene I Drigalenko; Eric C Brown; Jessica Freda; Catherine Leites; Harald H H Göring; Pablo V Gejman
Journal:  Hum Mol Genet       Date:  2015-05-28       Impact factor: 6.150

Review 6.  Childhood maltreatment and stress-related psychopathology: the epigenetic memory hypothesis.

Authors:  Pierre-Eric Lutz; Daniel Almeida; Laura M Fiori; Gustavo Turecki
Journal:  Curr Pharm Des       Date:  2015       Impact factor: 3.116

7.  DNA methylation analysis of Homeobox genes implicates HOXB7 hypomethylation as risk factor for neural tube defects.

Authors:  Anne Rochtus; Benedetta Izzi; Elise Vangeel; Sophie Louwette; Christine Wittevrongel; Diether Lambrechts; Yves Moreau; Raf Winand; Carla Verpoorten; Katrien Jansen; Chris Van Geet; Kathleen Freson
Journal:  Epigenetics       Date:  2015-01-29       Impact factor: 4.528

8.  TP53 Polymorphism Contributes to the Susceptibility to Bipolar Disorder but Not to Schizophrenia in the Chinese Han Population.

Authors:  Jialei Yang; Xulong Wu; Jiao Huang; Zhaoxia Chen; Guifeng Huang; Xiaojing Guo; Lulu Zhu; Li Su
Journal:  J Mol Neurosci       Date:  2019-05-05       Impact factor: 3.444

9.  Discrimination exposure and DNA methylation of stress-related genes in Latina mothers.

Authors:  Hudson P Santos; Benjamin C Nephew; Arjun Bhattacharya; Xianming Tan; Laura Smith; Reema Abdulrahman S Alyamani; Elizabeth M Martin; Krista Perreira; Rebecca C Fry; Christopher Murgatroyd
Journal:  Psychoneuroendocrinology       Date:  2018-08-16       Impact factor: 4.905

10.  Transcriptome-wide mega-analyses reveal joint dysregulation of immunologic genes and transcription regulators in brain and blood in schizophrenia.

Authors:  Jonathan L Hess; Daniel S Tylee; Rahul Barve; Simone de Jong; Roel A Ophoff; Nishantha Kumarasinghe; Paul Tooney; Ulrich Schall; Erin Gardiner; Natalie Jane Beveridge; Rodney J Scott; Surangi Yasawardene; Antionette Perera; Jayan Mendis; Vaughan Carr; Brian Kelly; Murray Cairns; Ming T Tsuang; Stephen J Glatt
Journal:  Schizophr Res       Date:  2016-07-20       Impact factor: 4.939

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.